Depression Market Size, Syndrome Report to 2015: Radiant Insights, Inc

Depression Market Share, Size, Syndrome, Pipeline

Review, H2 2015

Depression - Pipeline Review, H2 2015

Summary

Global Markets Direct's, 'Depression - Pipeline Review, H2 2015', provides an overview of the

Depression's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Depression,

complete with comparative analysis at various stages, therapeutics assessment by drug target,

mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates,

and featured news and press releases. It also reviews key players involved in the therapeutic

development for Depression and special features on late-stage and discontinued projects.

Access Full Report With TOC @ http://www.radiantinsights.com/research/depression-pipelinereview-h2-2015

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy

areas and nearly 3,000 indications. The report is built using data and information sourced from Global

Markets Direct's proprietary databases, Company/University websites, SEC filings, investor

presentations and featured press releases from company/university sites and industry-specific third

party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the

report undergoes periodic updation following a stringent set of processes that ensures that all the

profiles are updated with the latest set of information. Additionally, processes including live news &

deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent

developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain

competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce

first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed...